Walbert Timothy P

CIK 000134937616 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001349376

Recent Transactions

50 trades

Award
Kardigan, Inc.$KARD
Stock Option (Right to Buy)
2026-06-17+57,573→ 57,573 total
Award
Kardigan, Inc.$KARD
Common Stock
2026-06-17+20,706→ 20,706 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2026-06-15+3,772→ 3,772 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2026-06-15+1,980→ 1,980 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2026-06-02+7,490→ 17,270 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2026-05-29−3,977→ 0 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2026-05-29+3,977→ 9,680 total
Award
Odyssey Therapeutics, Inc.$ODTX
Stock Option (Right to Buy)
2026-05-07+27,393→ 27,393 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2025-06-12+44,000→ 44,000 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2025-06-09+32,250→ 32,250 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2025-05-29+3,977→ 3,977 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2025-05-29−5,703→ 0 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-05-29+5,703→ 5,703 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2025-05-29+6,268→ 6,268 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2025-05-20+6,650→ 9,780 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2025-02-24+3,130→ 3,130 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2024-06-20+44,000→ 44,000 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2024-06-05+9,279→ 9,279 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2024-06-05+5,703→ 5,703 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2024-06-05+8,779→ 8,779 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2024-04-01+73,014→ 73,014 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,174→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−34,929→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−4,285→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−17,448→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−21,426→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−49,935→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−49,198→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−12,854→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−35,645→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−20,697→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−45,843→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−17,823→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−17,823→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−71,290→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−104,786→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−73,798→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−14,759→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−44,278→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−616,772→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-10-06−1,650,000→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
2023-10-06−742,565→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−4,657→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−5,174→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−107,739→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units
2023-10-06−10,349→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Ordinary Shares
2023-10-06$116.50/sh−100,300→ 0 total
Disposition to Issuer
Horizon Therapeutics Public Ltd Co
Restricted Stock Units
2023-10-06−14,283→ 0 total
Award
Century Therapeutics, Inc.$IPSC
Stock Option (right to buy)
2023-06-27+44,000→ 44,000 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2023-06-12+1,417→ 1,417 total

Companies

Recent Filings

Address

C/O KARDIGAN, INC. 506 CARNEGIE CENTER DRIVE, SUITE 201

PRINCETON, NJ, 08540

View on SEC.gov